Eli Lilly LLY announced results from the phase III EMBER-3 study, which showed that treatment with its orally administered ...
Eli Lilly (LLY) reported positive Phase 3 data for its drug candidate imlunestrant as both a combination and monotherapy in ...
Eli Lilly announces $15 billion share buyback plan and 15% dividend boost amidst mixed technical signals. Investors are ...
The board of directors of Eli Lilly (LLY) and Company approved a new $15B share repurchase program. The company’s prior $5B share repurchase ...
BofA has reinstated coverage of 11 large-cap pharmaceutical and biotech stocks, with Eli Lilly (LLY), Gilead (GILD) and Merck ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Ro announced earlier that it is working with Eli Lilly (LLY) and Company to streamline access to Zepbound single-dose vials for Ro patients ...
The healthcare industry is set for growth due to the growing demand for quality treatments and ongoing progress in medical ...